PHILLIPS DUAL ACTION 0.25 ML — DIN 02247727
MINERAL OIL : 0.25 ML MAGNESIUM HYDROXIDE : 60 MG · BAYER INC · LIQUID · wholesale supply in Canada
Health Canada status: APPROVED
What is PHILLIPS DUAL ACTION?
PHILLIPS DUAL ACTION 0.25 ML contains MINERAL OIL : 0.25 ML MAGNESIUM HYDROXIDE : 60 MG. It is listed in the Health Canada Drug Product Database under DIN 02247727, held by BAYER INC, supplied as LIQUID for ORAL administration. Health Canada currently lists it as approved, status dated 10-Jun-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
Is there a generic Liquid Paraffin, Combinations in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
8 holders have a Canadian DIN containing Liquid Paraffin, Combinations, across 10 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| WARNER-LAMBERT CANADA INC. | 3 | 0 | AGAROL EML STRAWBERRY, AGAROL PLAIN EML, AGAROL VANILLA LAXATIVE LIQ | No marketed DIN |
| BAYER INC | 1 | 0 | PHILLIPS DUAL ACTION | No marketed DIN |
| BDH INC. | 1 | 0 | MILK OF MAGNESIA MINERAL OIL EMULSION | No marketed DIN |
| J EDDE LTD. | 1 | 0 | BISKAMOIL PWR | No marketed DIN |
| META PHARMACEUTICALS INC. | 1 | 0 | MILK OF MAGNESIA MINERAL OIL EMULSION | No marketed DIN |
| NUMARK LABORATORIES, INC. | 1 | 0 | AGAROL PLAIN | No marketed DIN |
| PENDOPHARM DIVISION OF PHARMASCIENCE INC | 1 | 0 | MAGNOLAX | No marketed DIN |
| THERAPEX DIVISION DE E-Z-EM CANADA INC | 1 | 0 | LAXAROL | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 0.25 ML |
|---|---|
| Dosage form | LIQUID |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Liquid Paraffin, Combinations |
|---|---|
| ATC code | A06AA51 |
| AHFS class | 56:12.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02247727 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2247727 |
| Brand name | PHILLIPS DUAL ACTION |
| Generic / active ingredient | MINERAL OIL : 0.25 ML MAGNESIUM HYDROXIDE : 60 MG |
| Market authorization holder | BAYER INC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A06AA51 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A06AA |
| Current status | APPROVED |
| Status date | 10-Jun-2003 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 10 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AGAROL EML STRAWBERRY | 1.6 ML / 5 ML | EMULSION | WARNER-LAMBERT CANADA INC. | CANCELLED POST MARKET | 01945963 |
| AGAROL PLAIN | 1.6 ML / 5 ML | EMULSION | NUMARK LABORATORIES, INC. | CANCELLED POST MARKET | 02237625 |
| AGAROL PLAIN EML | 800 MG / 5 ML | EMULSION | WARNER-LAMBERT CANADA INC. | CANCELLED POST MARKET | 01945971 |
| AGAROL VANILLA LAXATIVE LIQ | 1.6 ML / 5 ML | LIQUID | WARNER-LAMBERT CANADA INC. | CANCELLED POST MARKET | 01926012 |
| BISKAMOIL PWR | 15.42 G / 100 G | POWDER | J EDDE LTD. | CANCELLED POST MARKET | 00300160 |
| LAXAROL | 65 MG / 5 ML | LIQUID | THERAPEX DIVISION DE E-Z-EM CANADA INC | CANCELLED POST MARKET | 00628778 |
| MAGNOLAX | 0.25 ML | EMULSION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | DORMANT | 00202045 |
| MILK OF MAGNESIA MINERAL OIL EMULSION | 2.4 G / 30 ML | EMULSION | META PHARMACEUTICALS INC. | CANCELLED POST MARKET | 01916122 |
| MILK OF MAGNESIA MINERAL OIL EMULSION | 20 % / 30 ML | EMULSION | BDH INC. | CANCELLED POST MARKET | 02142996 |
2 · Same class — other molecules in ATC A06AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Docusate Sodium | AG-DOCUSATE SODIUM · ALBERT DOCUSATE · ALTA-DOCUSATE SODIUM · APO-DOCUSATE CALCIUM · +71 more | 101 | 16 | Yes |
| Liquid Paraffin | CANADIAN NATIONAL PHARMA GROUP INC MINERAL OIL HEAVY USP · FLEET ENEMA MINERAL OIL · GELEE LAXATIVE A LA FRAMBOISE · HEAVY MINERAL OIL · +20 more | 32 | 6 | Yes |
| Liquid Paraffin, Combinations | AGAROL EML STRAWBERRY · AGAROL PLAIN · AGAROL PLAIN EML · AGAROL VANILLA LAXATIVE LIQ · +5 more | 10 | 0 | Not in Canada |
| Docusate Sodium, Combinations | ACIDOBYL | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A06A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A06AB | Bisacodyl · Bisacodyl, Combinations · Cascara · Cascara, Combinations · Castor Oil · +9 more | 239 | 25 |
| A06AD | Lactulose · Macrogol · Macrogol, Combinations · Magnesium Oxide · Magnesium Sulphate · +5 more | 86 | 21 |
| A06AX | Glycerol · Linaclotide · Lubiprostone · Other Laxatives · Plecanatide · +2 more | 30 | 14 |
| A06AH | Methylnaltrexone Bromide · Naloxegol | 5 | 3 |
| A06AG | Bisacodyl · Combinations · Docusate Sodium, Incl Combinations · Sodium Phosphate | 7 | 1 |
| A06AC | Ispaghula (Psylla Seeds) · Ispaghula, Combinations · Linseed · Methylcellulose · Polycarbophil Calcium · +2 more | 79 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.